Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
145 | Frontiers in Anti-infective Drug Discovery | book series | 0.209 Q4 | 3 | 1 | 7 | 124 | 3 | 1 | 0.17 | 124.00 | 57.14 | |
144 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.104 Q4 | 14 | 0 | 9 | 0 | 0 | 9 | 0.00 | 0.00 | 0.00 | |
143 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.688 Q3 | 29 | 7 | 21 | 562 | 185 | 7 | 10.64 | 80.29 | 0.00 | |
142 | Drug Discovery Today: Disease Models | journal | 0.665 Q3 | 33 | 0 | 23 | 0 | 64 | 20 | 0.00 | 0.00 | 0.00 | |
141 | Turkish Computational and Theoretical Chemistry | journal | 0.191 Q4 | 8 | 17 | 30 | 667 | 43 | 30 | 0.89 | 39.24 | 23.64 | |
140 | Journal of Stem Cells | journal | 0.101 Q4 | 21 | 0 | 32 | 0 | 0 | 31 | 0.00 | 0.00 | 0.00 | |
139 | Pteridines | journal | 0.175 Q4 | 19 | 2 | 43 | 83 | 22 | 42 | 0.54 | 41.50 | 100.00 | |
138 | Drug Discovery Today: Technologies | journal | 1.241 Q1 | 62 | 0 | 53 | 0 | 295 | 48 | 3.50 | 0.00 | 0.00 | |
137 | MCB Molecular and Cellular Biomechanics | journal | 0.315 Q4 | 31 | 10 | 59 | 382 | 76 | 59 | 1.60 | 38.20 | 51.85 | |
136 | Molecular Imaging | journal | 0.514 Q3 | 66 | 9 | 60 | 606 | 128 | 60 | 1.97 | 67.33 | 42.42 | |
135 | Eurobiotech Journal | journal | 0.236 Q4 | 10 | 13 | 64 | 573 | 93 | 63 | 1.30 | 44.08 | 24.39 | |
134 | Biomarker Insights | journal | 0.974 Q2 | 40 | 9 | 67 | 468 | 246 | 59 | 3.34 | 52.00 | 50.00 | |
133 | Cell Stress | journal | 1.852 Q1 | 27 | 12 | 67 | 632 | 350 | 67 | 3.53 | 52.67 | 40.32 | |
132 | OBM Genetics | journal | 0.160 Q4 | 4 | 16 | 68 | 973 | 21 | 63 | 0.38 | 60.81 | 55.56 | |
131 | Expert Reviews in Molecular Medicine | journal | 1.357 Q1 | 93 | 30 | 72 | 4351 | 398 | 72 | 4.72 | 145.03 | 52.67 | |
130 | European Journal of Medicinal Chemistry Reports | journal | 0.588 Q3 | 11 | 22 | 86 | 1972 | 367 | 86 | 4.27 | 89.64 | 28.81 | |
129 | European Journal of Hybrid Imaging | journal | 0.479 Q3 | 14 | 28 | 87 | 773 | 183 | 87 | 1.73 | 27.61 | 37.23 | |
128 | Cellular Therapy and Transplantation | journal | 0.170 Q4 | 8 | 32 | 90 | 970 | 26 | 88 | 0.25 | 30.31 | 56.59 | |
127 | Genealogy | journal | 0.160 Q4 | 3 | 101 | 92 | 5348 | 63 | 87 | 0.68 | 52.95 | 57.07 | |
126 | Clinical and Translational Medicine | journal | 2.424 Q1 | 18 | 0 | 96 | 0 | 546 | 47 | 5.69 | 0.00 | 0.00 | |
125 | Pharmacogenetics and Genomics | journal | 0.563 Q3 | 152 | 25 | 97 | 907 | 208 | 95 | 1.94 | 36.28 | 51.45 | |
124 | Expert Review of Precision Medicine and Drug Development | journal | 0.257 Q4 | 16 | 3 | 102 | 251 | 92 | 79 | 0.90 | 83.67 | 42.86 | |
123 | Pharmacological Reviews | journal | 6.050 Q1 | 254 | 35 | 102 | 13259 | 2111 | 100 | 19.42 | 378.83 | 33.99 | |
122 | Molecular Biomedicine | journal | 1.455 Q1 | 16 | 49 | 107 | 6324 | 565 | 101 | 5.32 | 129.06 | 46.29 | |
121 | Human Genetics and Genomics Advances | journal | 1.713 Q1 | 13 | 69 | 110 | 3480 | 383 | 107 | 3.55 | 50.43 | 51.03 | |
120 | Advances in Biological Regulation | journal | 1.114 Q2 | 69 | 39 | 111 | 2651 | 395 | 105 | 2.77 | 67.97 | 43.71 | |
119 | Clinical Proteomics | journal | 1.015 Q2 | 42 | 55 | 117 | 3191 | 442 | 113 | 2.81 | 58.02 | 39.31 | |
118 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.168 Q4 | 16 | 12 | 118 | 408 | 61 | 118 | 0.59 | 34.00 | 45.45 | |
117 | Nucleic Acid Therapeutics | journal | 1.252 Q1 | 77 | 33 | 125 | 1583 | 502 | 122 | 3.95 | 47.97 | 38.46 | |
116 | Assay and Drug Development Technologies | journal | 0.317 Q4 | 65 | 32 | 126 | 1530 | 234 | 118 | 1.61 | 47.81 | 37.21 | |
115 | Clinical and Translational Discovery | journal | 0.271 Q4 | 5 | 86 | 140 | 4700 | 84 | 51 | 0.60 | 54.65 | 38.59 | |
114 | NeuroMolecular Medicine | journal | 1.001 Q2 | 82 | 52 | 146 | 2913 | 554 | 145 | 3.76 | 56.02 | 43.94 | |
113 | Personalized Medicine | journal | 0.412 Q3 | 36 | 43 | 146 | 1840 | 255 | 138 | 1.62 | 42.79 | 49.20 | |
112 | SAR and QSAR in Environmental Research | journal | 0.359 Q4 | 54 | 49 | 147 | 2680 | 414 | 147 | 2.58 | 54.69 | 35.87 | |
111 | Extremophiles | journal | 0.726 Q3 | 95 | 29 | 151 | 1759 | 465 | 151 | 2.51 | 60.66 | 41.89 | |
110 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 41 | 153 | 1868 | 578 | 152 | 3.76 | 45.56 | 30.72 | |
109 | Molecular Cytogenetics | journal | 0.403 Q4 | 38 | 36 | 160 | 1356 | 225 | 159 | 1.43 | 37.67 | 62.60 | |
108 | Journal of Peptide Science | journal | 0.352 Q4 | 73 | 78 | 164 | 3861 | 288 | 163 | 1.74 | 49.50 | 40.52 | |
107 | Vaccine: X | journal | 0.682 Q3 | 18 | 163 | 168 | 6099 | 452 | 168 | 2.80 | 37.42 | 49.48 | |
106 | Journal of Experimental Zoology Part B: Molecular and Developmental Evolution | journal | 0.781 Q2 | 70 | 58 | 169 | 3259 | 314 | 141 | 1.66 | 56.19 | 39.25 | |
105 | Molecular Aspects of Medicine | journal | 2.748 Q1 | 159 | 59 | 172 | 9151 | 1731 | 156 | 7.87 | 155.10 | 41.13 | |
104 | Molecular Informatics | journal | 0.550 Q3 | 75 | 54 | 172 | 2684 | 517 | 167 | 2.90 | 49.70 | 33.72 | |
103 | Function | journal | 0.987 Q2 | 16 | 74 | 173 | 3180 | 401 | 136 | 2.18 | 42.97 | 39.01 | |
102 | Molecular Diagnosis and Therapy | journal | 1.214 Q2 | 68 | 55 | 174 | 4152 | 719 | 171 | 4.28 | 75.49 | 45.53 | |
101 | Human Genomics | journal | 1.199 Q2 | 68 | 113 | 186 | 6418 | 681 | 176 | 3.51 | 56.80 | 49.55 | |
100 | Vascular Pharmacology | journal | 0.969 Q2 | 108 | 66 | 187 | 3575 | 665 | 183 | 3.64 | 54.17 | 44.68 | |
99 | Cold Spring Harbor molecular case studies | journal | 0.801 Q2 | 25 | 38 | 190 | 1110 | 337 | 189 | 1.80 | 29.21 | 45.85 | |
98 | Blood Cells, Molecules, and Diseases | journal | 0.584 Q3 | 98 | 32 | 192 | 1217 | 313 | 154 | 1.65 | 38.03 | 52.46 | |
97 | Drugs in Context | journal | 0.811 Q2 | 36 | 58 | 193 | 3370 | 574 | 193 | 2.46 | 58.10 | 41.20 | |
96 | Pharmacogenomics Journal | journal | 0.659 Q3 | 95 | 28 | 194 | 1215 | 524 | 193 | 2.58 | 43.39 | 40.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®